What is the GDTC stock price prediction for next 2 weeks?

According to our price prediction algorithm,CytoMed Therapeutics Limited (GDTC) price will be around $0.57 in the next 2 weeks. This means it will decrease by -32.509707024355805 from the last closing price. This prediction may vary from other time period filters for GDTC stock.

What can be the highest Possible price of GDTC stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, GDTC can achieve the highest price of $0.67 which is -21.417763087222507 lower than last closing price. This prediction may vary from other time period filters for GDTC stock.

What can be the lowest Possible price of GDTC stock in next 2 weeks?

As per the forecast and algorithmic analysis, GDTC stock price can be as low as $0.48 which is -43.090882837367836 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for GDTC stock.

Will GDTC stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that GDTC stock will lose-32.509707024355805 in the next 2 weeks. This prediction may vary from other time period filters for GDTC stock.

What is GDTC stock last closing price?

Last closing price of GDTC stock was $1.08.

What is GDTC stock price prediction?

GDTC stock price prediction means predicting the future closing prices of GDTC stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of GDTC stock in a certain time period.

How we predict GDTC stock future prices?

If you are searching for GDTC stock forecast, analysis or price prediction, then you might be wondering what CytoMed Therapeutics Limited (GDTC) will do in the future. Our GDTC price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This GDTC price prediction will likely answer most of your questions.

How frequent we update GDTC stock predictions?

We are updating the forecasts for the GDTC stock on daily basis.

Is using ML forecasting for GDTC stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for GDTC stock same for all the time periods?

No, the prediction for GDTC stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

CytoMed Therapeutics Limited Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.0813.67%Since 2 Weeks

Predicted Price$0.57-32.51%For 2 Weeks

Upper Predicted Price$0.67-21.42%For 2 Weeks

Lower Predicted Price$0.48-43.09%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of GDTC will decline by -32.51% over the next 2 Weeks and hit $0.57 by Wednesday, February 18, 2026. In that time frame, GDTC's share price is expected to range between $0.48 and $0.67.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 18, 2026	0.48	0.57	0.67
Feb 17, 2026	0.52	0.62	0.71
Feb 16, 2026	0.55	0.64	0.75
Feb 13, 2026	0.57	0.66	0.75
Feb 12, 2026	0.55	0.65	0.74
Feb 11, 2026	0.60	0.70	0.79
Feb 10, 2026	0.65	0.75	0.85
Feb 9, 2026	0.68	0.77	0.87
Feb 6, 2026	0.69	0.78	0.88
Feb 5, 2026	0.67	0.77	0.86

GDTC shares rose +27.07% in Thursday, February 5, 2026's trading session, rising from a previous close of $0.85 to move at $1.08. The stock demonstrated notable intraday movement (see GDTC's key stats for a full breakdown), fluctuating between $0.90 and $1.25, a +38.70% trading range. While recent weeks have seen some volatility, GDTC has managed to secure a +8.00% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 21.76M shares changing hands, 15.78M more than the previous session. This amounted to $23.50M in total market activity.

Will GDTC Continue Its Downward Trend?

According to analyst ratings and projections for GDTC, CytoMed Therapeutics Limited shares are anticipated to decrease by -61.71%, potentially reaching $0.67 per share by February 18, 2026. Short-term technical indicators for GDTC currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the GDTC stock forecast, now is not the best time to buy GDTC stock because its current trading price is +88.28% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on GDTC covering social and institutional perspectives.

GDTC Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into GDTC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.55% to 59.46%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 42.24%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.47%, maintains a neutral outlook for the long term. Insights into GDTC's shareholder base show how institutional investors are positioning themselves during these momentum shifts

CytoMed Therapeutics Short-Term Forecasts

GDTC Forecast For Next 5 Days

Our algorithm anticipates CytoMed Therapeutics (GDTC) stock could hit $0.69 by Feb 12, 2026. This represents a -35.67% fall from today's price, following a -15.32% change over the past five days.

GDTC Forecast For Next 30 Days

Based on analysis of market trends, the outlook for CytoMed Therapeutics Limited (GDTC) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.54, which would mean a -50.00% decrease from the current price of $1.08. Projections for this period range from a high of $0.90 to a low of $0.28.

GDTC Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for CytoMed Therapeutics's price over the next three months point to a rise. GDTC stock is expected to peak at $4.36 on Feb 06, 2026 before potentially dipping to $1.53 on Apr 10, 2026. On average, GDTC is likely to trade around $2.49 in the coming 90 days.

CytoMed Therapeutics Stock Forecast 2025

Based on our predictive models, CytoMed Therapeutics (GDTC) is expected to trade between $0.00 and $4.36 throughout 2026. This would result in an average price of $1.45, potentially offering investors a +34.26% return from current levels.

CytoMed Therapeutics Limited Monthly Forecast 2026–2027

February 2026

According to our latest forecast models, CytoMed Therapeutics Limited (GDTC) is positioned to show a strong performance in February 2026. The price is predicted to move between $2.89 and $4.36, settling at an average of $3.58. This could translate to a +231.48% gain.

March 2026

Based on current market signals, CytoMed Therapeutics Limited is projected to trend march 2026. We forecast a trading range from $1.82 to $3.03, with a likely average price of $2.52. Investors could expect a potential return of +133.33%.

April 2026

Our predictive algorithms indicate CytoMed Therapeutics Limited stock may see a shift in April 2026. The expected range spans $1.53–$2.02, with an average target of $1.78. This represents a positive outlook and a possible gain of +64.81%.

May 2026

Analyzing established trends, CytoMed Therapeutics Limited looks set to move in May 2026. Projections place the stock between $1.21 and $1.93, averaging around $1.52. This suggests a +40.74% gain from current levels.

June 2026

Market indicators suggest CytoMed Therapeutics Limited could experience notable changes during June 2026. Prices could fluctuate within $1.04 to $1.57, with a midpoint forecast of $1.37. The stock might deliver a +26.85% gain.

July 2026

Forecasting for July 2026, models estimate that CytoMed Therapeutics Limited may undergo key fluctuations. If trends hold, the stock might trade between $0.76 and $1.59, averaging $1.40. This signals a positive trajectory with potential returns around +29.63%.

August 2026

According to our latest forecast models, CytoMed Therapeutics Limited (GDTC) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.33 and $1.20, settling at an average of $0.97. This could translate to a -10.19% loss.

September 2026

Based on current market signals, CytoMed Therapeutics Limited is projected to trend september 2026. We forecast a trading range from $0.18 to $0.81, with a likely average price of $0.86. Investors could expect a potential return of -20.37%.

October 2026

Our predictive algorithms indicate CytoMed Therapeutics Limited stock may see a shift in October 2026. The expected range spans $0.00–$0.76, with an average target of $0.94. This represents a cautious outlook and a possible loss of -12.96%.

November 2026

Analyzing established trends, CytoMed Therapeutics Limited looks set to move in November 2026. Projections place the stock between $0.00 and $0.56, averaging around $0.90. This suggests a -16.67% loss from current levels.

December 2026

Market indicators suggest CytoMed Therapeutics Limited could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $0.28, with a midpoint forecast of $0.72. The stock might deliver a -33.33% loss.

January 2027

Forecasting for January 2027, models estimate that CytoMed Therapeutics Limited may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.51. This signals a cautious trajectory with potential returns around -52.78%.

February 2027

According to our latest forecast models, CytoMed Therapeutics Limited (GDTC) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.34. This could translate to a -68.52% loss.

GDTC's history of dividends and stock splits also plays a role in long-term investor confidence.